Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Powers

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2004
Issues in clinical trials of prophylaxis of fungal infectionsJohn H Powers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2006
Salvage therapy trials in invasive fungal disease: challenges and opportunitiesJohn H Powers
BMJ (Clinical Research Ed.)|June 5, 2024
Antimicrobial stewardshipJohn H Powers
Pharmacotherapy|November 25, 2005
Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trialsJohn H Powers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2020
Scientific Evidence, Regulatory Decision Making, and Incentives for Therapeutics in Infectious Diseases: The Example of CefiderocolJohn H Powers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Empirical antifungal therapy in febrile neutropenic patients: caution about composite end points and the perils of P valuesJohn H Powers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2012
Editorial commentary: Asking the right questions: morbidity, mortality, and measuring what's important in unbiased evaluations of antimicrobialsJohn H Powers
Statistics in Medicine|January 11, 2008
Noninferiority and equivalence trials: deciphering 'similarity' of medical interventionsJohn H Powers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2009
Risk perception and inappropriate antimicrobial use: yes, it can hurtJohn H Powers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
Recommendations for improving the design, conduct, and analysis of clinical trials in hospital-acquired pneumonia and ventilator-associated pneumoniaJohn H Powers
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2004
Issues in clinical trials of prophylaxis of fungal infectionsJohn H Powers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2006
Salvage therapy trials in invasive fungal disease: challenges and opportunitiesJohn H Powers
BMJ (Clinical Research Ed.)|June 5, 2024
Antimicrobial stewardshipJohn H Powers
Pharmacotherapy|November 25, 2005
Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trialsJohn H Powers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2020
Scientific Evidence, Regulatory Decision Making, and Incentives for Therapeutics in Infectious Diseases: The Example of CefiderocolJohn H Powers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Empirical antifungal therapy in febrile neutropenic patients: caution about composite end points and the perils of P valuesJohn H Powers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2012
Editorial commentary: Asking the right questions: morbidity, mortality, and measuring what's important in unbiased evaluations of antimicrobialsJohn H Powers
Statistics in Medicine|January 11, 2008
Noninferiority and equivalence trials: deciphering 'similarity' of medical interventionsJohn H Powers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2009
Risk perception and inappropriate antimicrobial use: yes, it can hurtJohn H Powers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
Recommendations for improving the design, conduct, and analysis of clinical trials in hospital-acquired pneumonia and ventilator-associated pneumoniaJohn H Powers
Pageof 17